Clinical Trial Update: Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating camrelizumab for locally advanced nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Wei Jiang | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN